Home›Stock Screener›Pfizer›P/E Ratio

Pfizer P/E Ratio

Current P/E Ratio
20.3
Moderate Valuation
High - Growth expectations or overvalued

Pfizer P/E ratio. Pfizer (PFIZER) P/E ratio is 20.3 (Moderate), EPS (TTM) ₹157.92, current price ₹3850.30 on NSE — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see PFIZER screener.

Current Valuation Metrics

P/E Ratio 20.3
Current Price ₹3850.30
EPS (TTM) ₹157.92
Exchange NSE

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 52.32
Sector Median 29.6
Sector Rank #11 of 255
Sector Percentile 4.3%

PFIZER P/E Ratio — Valuation Signal & Historical Context

Pfizer P/E 20.3 — signal: Overvalued. Check Pfizer market worth to track the company's total market size over time.

  • Trading at discount to sector average PE of 52.32

PFIZER vs Healthcare Peers — P/E Ratio Comparison

Pfizer P/E 20.3 vs Healthcare average 52.32, median 29.6 — range 2.0–733.0.

Sector Average
52.32
Sector Median
29.6
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low